Est. 2014, London-based. AUM €9bn (largest EU healthcare PE specialist). Fund IV closed Oct 2025 €2.5bn. 75+ professionals across Europe/US. Portfolio: 26 platform companies (post-Fund III); recent platforms incl. Avid Bioservices (CDMO, $1.1bn deal), Scientist.com (AI R&D platform), FotoFinder (diagnostics), Velocity Clinical Research. Value-add: operational excellence, vertical integration, global scaling.
Investment Focus
Investment Thesis
Specialist mid-market healthcare PE, €30-150m c.£25-130m checks. Focus: BioPharma, MedTech, CDMO, Life Science Tools/Diagnostics, Healthcare IT, Advisory/Data, Pharma Services. Transatlantic playbook—pan-European & US expansion. Sector expertise differentiator: deep ops team, proprietary network, thematic approach. Avoids early-stage venture, pure biotech.
Interested in connecting?
Visit their website or reach out directly.